INTRODUCTION
Systemic lupus erythematosus (SLE) is one of the most frequent autoimmune rheumatological diseases. One of its major characteristics is the presence of multiple autoantibodies, and several organs and systems are the possible targets in the disease. It affects mainly child-bearing-age women, at the proportion of 8-12:1. SLE has high morbidity rate, and death is a possible consequence. 1, 2 Although the factors contributing to the pathogeny of SLE have not yet been completely clarifi ed, genetic mechanisms, and environmental, hormonal and immune factors are known to be implicated. 2 Among the environmental factors, vitamin D has been subject of an increasing number of studies in recent years, which have demonstrated its role in autoimmunity. [3] [4] [5] [6] Vitamin D is a steroidal hormone, whose major function consists in the regulation of calcium homeostasis, bone formation and resorption, via its interaction with parathyroid glands, kidneys and intestines. 3 Endogenous formation in skin tissues after exposure to ultraviolet B (UVB) radiation is the major source of vitamin D, which exerts its biological effect through its receptor (VDR), which is widely distributed in the body, including the immune system cells. 3 The wide distribution and expression of the VDR in most immune cells, such as monocytes, macrophages, dendritic cells, natural killer cells, and T and B lymphocytes, in addition to its effect on cell proliferation and differentiation, make vitamin D a potential candidate for immune system regulation. 7 Patients with SLE have multiple risk factors for vitamin D deficiency. The photosensitivity characteristic of SLE determines a lower sun exposure and the use of sunscreen, which blocks UVB radiation, reducing the skin production of vitamin D. Chronic use of corticosteroids, drugs of frequent use in the treatment of patients with SLE, changes the vitamin D metabolism. In addition, severe renal impairment, which can occur in patients with lupus nephritis, can change the stage of hydroxylation of vitamin D. 8 Some studies have linked vitamin D insuffi ciency/deficiency with several autoimmune diseases, such as insulindependent diabetes mellitus, 9 multiple sclerosis, 10 infl ammatory bowel disease, 4 and SLE. 4, 5, 11, 12 Thus, vitamin D insuffi ciency/ defi ciency is suggested to be an extrinsic factor capable of modifying the prevalence of autoimmune diseases, such as SLE, 5 and interfering with their severity. 11, 12 Studies carried out with healthy individuals in Brazil, in the cities of Recife 13 and São Paulo, 14 have shown a high prevalence of vitamin D insuffi ciency/defi ciency. Given this context, the present study aimed to determine the serum levels of 25- 17 and insuffi ciency/defi ciency as values < 30 ng/mL. Anti-DNA was assessed by Crithidia immunofl uorescence. 18 The association of 25(OH)D insuffi ciency/defi ciency with the following variables was assessed: time to diagnosis, fatigue by visual analogue scale (VAS), 19 disease activity with SLEDAI, 20 corticosteroid and chloroquine use, and anti-DNA.
Data analysis comprised absolute and percentage distributions of the variables in the nominal scale and, for numerical variables, the measures of mean descriptive statistics, standard deviation, and minimum and maximum values. To assess the individual association between independent variables and presence of 25(OH)D insuffi ciency/defi ciency, univariate analysis was performed by using Pearson chi-square test. The mean ages and 25(OH)D levels between the SLE and comparison groups were compared by use of Student t test for independent samples, with 95% confi dence interval.
Data were entered in MS Excel software, and statistical analysis was performed with SPSS software, version 17.0. The signifi cance level adopted was 5.0%. 
RESULTS
Insufficiency/deficiency of 25(OH)D was observed in 45 of 78 patients with SLE (57.7%) and in 25 of 64 individuals of the comparison group (39%). Table 1 shows the clinical, epidemiological and laboratory variables of patients studied.
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Mean serum levels of 25(OH)D were 29.3 ng/mL (6.1-55.2 ng/mL) and 33.12 ng/mL (15.9-63.8 ng/mL) in the SLE and comparison groups, respectively. This difference was considered statistically signifi cant. No statistically signifi cant difference was observed between mean ages in both groups (Table 2) .
No statistically signifi cant association was observed between 25(OH)D insuffi ciency/defi ciency and time to diagnosis, disease activity (SLEDAI ≥ 6), fatigue, use of corticosteroids and antimalarials, and anti-DNA (Table 3) .
DISCUSSION
Vitamin D is an essential nutrient for several organs and tissues, being involved in multiple biological processes, in addition to bone metabolism. In recent years, the several "roles" of vitamin D have been highlighted. A recent meta-analysis has suggested that a reduction could occur in the mortality rate of individuals undergoing supplementation. 21 In addition to its importance in general health, vitamin D has multiple immunoregulatory actions, and can be implicated in the etiopathogenesis of autoimmune diseases. 22 Although present in several foods, its major source is still represented by its endogenous formation in cutaneous tissues after exposure to UVB radiation. 23 Depending on the latitude, 24 However, "modern life" habits increasingly lead us to avoid the endogenous synthesis of vitamin D.
The city of Recife, in the Brazilian state of Pernambuco, where the investigation was carried out, has tropical, warm and humid climate, with mean annual temperature of 25.2 ºC. Recife is located at latitude of 8º 04' 03" South and longitude of 34º 55' 00" West, and high insolation indices throughout the year. 25 The two groups of patients in this study were from Recife and other regions of the state of Pernambuco, where there are areas with even higher insolation indices and mean annual temperatures.
Despite of the geographical location and climate characteristics, inadequate serum levels of 25(OH)D (< 30 ng/mL) were found in 57.7% of the patients with SLE and 39% of those in the comparison group. Mean serum levels were lower in the SLE group (29.3 ng/mL) as compared with those in the comparison group (33.12 ng/mL), and the difference was statistically signifi cant.
The high prevalence of vitamin D insuffi ciency/defi ciency found in this study, which was carried out in a high insolation region, is similar to that of other studies, which have shown inadequate 25(OH)D levels in 50%-75% of patients with SLE both in low 6, 8, 26 and high 27 insolation regions. The high prevalence of vitamin D insuffi ciency/defi ciency found in our patients in this study is believed to result from the recommendations to use sunscreen and mainly to avoid sun exposure.
Although 78.2% of the patients with SLE in this study used corticosteroids, no association was found between their use and vitamin D insuffi ciency/defi ciency. However, information bias should be considered, due to the impossibility of measuring the regularity of use of corticosteroids and their cumulative dose.
Chloroquine can inhibit 1α-hydroxylation of 25(OH)D, causing a decrease in the levels of its more active metabolite, without, however, causing alterations in 25(OH)D levels. 28 In this study, no association was found between vitamin D insuffi ciency/defi ciency and chloroquine use, in accordance with the study by Huisman et al. 23 Those authors, however, have reported reduced serum levels of 1,25 dihydroxy vitamin D (1,25(OH) 2 D), which were not measured in this study.
Regarding disease activity, controversy about the infl uence of serum levels of 25(OH)D in patients with SLE seems to exist. Similarly to the fi ndings in other studies, 8, 27, 29 no association with disease activity was observed, although those studies have used different cutoff points for SLEDAI. Recently, Borba et al. 11 and
Amital et al. 12 have described an association between 25(OH)D serum levels and disease activity. Considering the immunoregulatory functions of vitamin D already reported, patients with SLE and low 25(OH)D serum levels would be expected to have more severe and more often active disease. However, data in the literature are controversial. This can result from the different methodologies used, study designs, characteristics of the patients, and varied cutoff points for SLEDAI and 25(OH)D. In addition, a cutoff point from which 25(OH)D would interfere with disease activity is not known. Thus, more studies with larger populations are required to defi ne the actual role of vitamin D in the activity of disease in patients with SLE and to defi ne from which 25(OH)D serum levels the disease activity would be infl uenced.
Vitamin D defi ciency has been identifi ed as the cause of muscular weakness and myalgia in elderly patients, 30, 31 and an association of low 25(OH)D serum levels with fatigue in patients with SLE has been reported. 8 Although fatigue was present in 66.6% of patients with SLE, no association with 25(OH)D insuffi ciency/defi ciency has been identifi ed. This study did not assess the association between fatigue in patients with SLE and disease activity, use of drugs, and comorbidities. These factors could justify the prevalence of fatigue observed in patients with SLEs in this study.
In this study, no association was observed between vitamin D insuffi ciency/defi ciency and the time to diagnosis. Serum levels of 25(OH)D lower than 30 ng/mL were observed in 15 of 22 patients (68.2%) diagnosed with SLE within less than three years. This suggests that in the fi rst years of diagnosis, vitamin D insuffi ciency/defi ciency can occur. Thus, measuring 25(OH)D should be recommended at the time SLE is diagnosed, because high prevalence of vitamin D insuffi ciency/defi ciency has also been reported in previously healthy individuals, 31, 32 as well as in the fi rst years of the disease.
The association between vitamin D insuffi ciency/defi ciency and anti-DNA in patients with SLE is controversial. This study found no association, in accordance with that by Toloza et al., 6 and contrary to that by Carvalho et al., 33 who reported an association between 25(OH)D serum levels and presence of anti-DNA. More studies are required to assess the association of the autoantibody profi le and 25(OH)D serum levels.
Vitamin D insuffi ciency/defi ciency seems not to be an exclusivity-of patients with SLE, although such patients usually have lower mean serum levels than the healthy population, as shown in this study. Inadequate vitamin D levels also occur in healthy children, young adults, elderly, and hospitalized patients. 17 This relationship has also been verifi ed in a recent meta-analysis 31 with healthy Caucasian individuals.
In the present study, the percentage of vitamin D insufficiency/defi ciency in the comparison group (25/64, 39%), was similar to that of European studies (40%-80% prevalence) described in a recent review. 32 That high prevalence reported for healthy individuals is likely to result from "modern life" activities, which make us avoid sun exposure, and, consequently, reduce vitamin D synthesis.
The major limitation of this study was the impossibility to assess the cumulative dose of corticosteroids in patients using or who had used those drugs and the regularity of sunscreen use. The infl uence of ethnicity was not assessed in this study, because that variable is diffi cult to defi ne in the Brazilian population. Another diffi culty was the comparison of the results in this study with those of other studies, due to the different levels of insolation of the regions assessed. In addition, other aspects, such as methodology, study design, characteristics of patients, and varied cutoff points for SLEDAI, made comparisons diffi cult.
In conclusion, according to this study's fi ndings, 57.7% of patients with SLE showed low 25(OH)D serum levels, which were signifi cantly lower than those in the comparison group. No association between vitamin D insuffi ciency/defi ciency and the following was observed: time to diagnosis; disease activity; fatigue; anti-DNA; and use of corticosteroids and chloroquine.
Thus, considering the multiple "roles" of vitamin D, we emphasize the importance of determining 25(OH)D serum levels in all patients with SLE, regardless of where they live and the time to disease diagnosis.
